Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Dengue Fever Cases Drop 91% in Neighbourhood of Piracicaba, Brazil, Where Oxitec's Friendly™ Aedes Were Released


News provided by

Oxitec Ltd

14 Jul, 2016, 13:00 GMT

Share this article

Share toX

Share this article

Share toX

This image opens in the lightbox
OXITEC Logo (PRNewsFoto/Oxitec)

OXFORD, England, July 14, 2016 /PRNewswire/ --

Epidemiological surveillance year ended in July 2016 with 12 cases reported for the disease in CECAP/Eldorado, compared to 133 in the year that preceded it 

Piracicaba's Epidemiologic Surveillance service released new data this week which showed a 91% reduction of dengue fever cases registered in the CECAP/Eldorado district, an area of 5,000 residents, in the 2015/2016 dengue-year as compared to the 2014/2015 period. The incidence decreased to just 12 cases in 2015/2016, the first year in which Friendly™ Aedes, the genetically engineered mosquitoes that fight wild Aedes aegypti, were released there, versus 133 cases in the previous year. According to Epidemiologic Surveillance the rest of the municipality saw a 52% reduction in dengue fever incidence during the same period, from 3,487 cases in the 2014/2015 period to 1,676 cases in 2015/2016.

     (Logo: http://photos.prnewswire.com/prnh/20150630/227348 )

Additionally, the overall incidence rate in CECAP/Eldorado for the dengue-year 2014/2015 was 195% larger than the rate recorded for the rest of the municipality. In the dengue-year 2015/2016, the rate in CECAP/Eldorado was 45% lower than the rate in the rest of the municipality. The latest data roundup also reports zero cases of Zika and chikungunya in CECAP/Eldorado.

   
    Area                        Dengue Year**
                          2014/2015        2015/2016
    Piracicaba*
    Cases of Dengue          3,487            1,676
    Population             386,449          386,449
    Incidence               0.902%           0.437%

    CECAP/Eldorado
    Cases of Dengue            133               12
    Population               5,000            5,000
    Incidence                2.66%            0.24%

* Data excludes CECAP/Eldorado

** Dengue year in Brazil starts in 27th week of the calendar year and ends in 26th week of following calendar year

"Over the course of one year, we were able to bring the dengue fever incidence down by more than 50% in Piracicaba -- the outcome of diligent work to eliminate still water spots, the breeding site of the mosquito," says the city's Secretary of Health, Pedro Mello. "In CECAP/Eldorado, where we had the Friendly™ Aedes project, the reduction was extraordinary, going over 90%."

"We are delighted with the result achieved so far by Friendly™ Aedes which shows the potential of our approach. We hope to see this effect on a larger scale beyond the limited area of CECAP/Eldorado with our expansion into Piracicaba's downtown city," says Glen Slade, Oxitec do Brasil director.

Dengue-year 

The dengue-year in Brazil starts in the 27th week of the calendar year and ends in the 26th week of the following year. This period is used by health surveillance services as a standard for monitoring and reporting epidemiological data of diseases transmitted by Aedes aegypti. The incidence rate for a disease in a certain area is an important element in planning the fight against the disease.

Friendly™ Aedes

Produced by Oxitec do Brasil, Friendly™ Aedes have been used in Piracicaba since April 30th 2015, when the first insects were released in CECAP/Eldorado. In January 2016, the technology had already reduced the number of wild Aedes aegypti larvae by 82% in the treated area, compared to a non-treated area.

The success in reducing the population of wild Aedes aegypti led the City Hall to extend the project at CECAP/Eldorado for one more year. The deployment of Friendly™ Aedes was expanded into the city's downtown area, comprising an area of 11 neighbourhoods and 60,000 residents. The first Friendly™ Aedes to be deployed in the downtown area are expected to be released in the São Judas neighbourhood by the second half of July. A contract for the expansion of the Friendly™ Aedes project into the downtown area was signed on May 31st. Besides São Judas, the project is intended to benefit São Dimas, Centro, Clube de Campo, Cidade Jardim, Cidade Alta, Parque da Rua do Porto, Nhô Quim, Jardim Monumento, Nova Piracicaba and Vila Rezende.

How Friendly™ Aedes works

Oxitec has been working in Aedes aegypti control for more than a decade. It is a pioneer in the use of a biological method to suppress wild populations of this dangerous mosquito species through the release of Friendly™ Aedes males, which don't bite and don't transmit disease. When released, these males search for wild females to mate, and their offspring inherit a self-limiting gene that makes them die before reaching functional adulthood. Friendly™ Aedes' offspring also inherit a fluorescent marker that makes them easy to identify in the laboratory. This allows tracking and measuring at a level never before achieved, making effectiveness assessment and monitoring more accurate throughout the whole Friendly™ Aedes deployment programme.

Unlike other approaches, Friendly™ Aedes mosquitoes don't leave any ecological footprint. Friendly™ Aedes die along with their offspring, so that their presence doesn't linger in the environment.

About Oxitec 

Oxitec is a pioneer in using genetic engineering to control insect pests that spread disease and damage crops, and was founded in 2002 as a spinout from Oxford University (UK). Oxitec is a subsidiary of Intrexon Corporation (NYSE: XON), which engineers biology to help solve some of the world's biggest problems. Follow us on Twitter at @Oxitec.

Oxitec Contact: 

Matthew Warren
Press Officer
+44-(0)1235-832-393
info@oxitec.com

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.